Clinical Trials Directory

Trials / Terminated

TerminatedNCT01097447

Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)

Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

Status
Terminated
Phase
Study type
Observational
Enrollment
2,619 (actual)
Sponsor
Cxlusa · Industry
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication

Conditions

Timeline

Start date
2009-12-01
Primary completion
2017-04-30
Completion
2017-04-30
First posted
2010-04-01
Last updated
2018-10-11

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01097447. Inclusion in this directory is not an endorsement.